Cidara Therapeutics CFO to take principal accounting officer role
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
Infographic 2022 Top Tech Trends Shaping Corporations
Matthew Onaitis will assume the role of principal accounting officer after Marc Wilson resigns as principal accounting officer of Cidara Therapeutics Inc., effective Jan. 3, 2018.
Onaitis has been serving as the CFO, general counsel and secretary since July 2016.